Artificial intelligence (AI) is transforming healthcare in many ways, and fertility medicine is no exception. One of the most promising applications of AI is in in vitro fertilization (IVF), where it is being used to support embryo selection and assist fertility specialists in making more informed clinical decisions.
IVF has helped millions of people build their families, but success depends on many factors, including age, embryo quality, and the underlying cause of infertility. While AI cannot guarantee pregnancy, emerging research suggests it may help improve certain aspects of the IVF process by providing more consistent and data-driven assessments.
As this technology continues to evolve, AI has the potential to become an important tool in reproductive medicine while still working alongside experienced embryologists and fertility specialists.
Note: This article is for educational purposes only and should not replace medical advice from your fertility specialist or healthcare provider.
Embryo selection is one of the most important stages of the IVF process.
After eggs are retrieved and fertilized in the laboratory, several embryos may begin developing. Fertility specialists must then decide which embryo or embryos have the greatest likelihood of resulting in a healthy pregnancy.
Traditionally, embryologists evaluate embryos by examining their appearance and development under a microscope. They assess factors such as:
These visual assessments have been an essential part of IVF for many years, but they also rely on clinical expertise and interpretation.
Artificial intelligence can analyze large amounts of data far more quickly than humans.
In IVF, AI systems are trained using thousands of images and clinical outcomes to recognize patterns associated with embryo development.
Rather than replacing embryologists, AI functions as a clinical decision-support tool, providing additional information that may help identify embryos with a higher likelihood of successful implantation.
This approach may improve consistency while reducing some of the subjectivity involved in traditional visual assessment.
Many fertility clinics now use time-lapse incubators that continuously photograph developing embryos without removing them from their controlled environment.
AI can analyze these images to evaluate:
Some studies suggest these patterns may provide additional information that helps clinicians assess embryo quality. However, research is ongoing, and the effectiveness of AI tools may vary depending on the specific technology and patient population.
Some fertility clinics use Preimplantation Genetic Testing (PGT) to screen embryos for certain chromosomal abnormalities before transfer.
AI does not replace genetic testing, but researchers are exploring how AI may complement existing techniques by combining information from embryo images, clinical data, and laboratory findings.
The goal is to support more informed embryo selection while reducing unnecessary procedures whenever possible.
One of AI’s greatest strengths is its ability to analyze complex information from many different sources.
Future AI systems may help fertility clinics consider factors such as:
By analyzing this information together, AI may help support more personalized treatment planning and assist clinicians in tailoring care to individual patients.
It’s important to remember that treatment decisions should always be made by qualified healthcare professionals who consider the complete clinical picture.
Although AI is showing promise in fertility medicine, several important challenges remain.
Many AI systems are still being evaluated through clinical research. Scientists continue to study whether these technologies consistently improve pregnancy and live birth rates across different patient groups and fertility clinics.
AI relies on large amounts of patient data, including medical records and, in some cases, genetic information. Protecting patient privacy and ensuring secure data management remain essential.
Advanced AI technologies may not yet be available in every fertility clinic, and access can vary depending on location and healthcare resources.
Expanding access while maintaining high-quality care will be an important consideration as these technologies continue to develop.
AI is designed to assist—not replace—fertility specialists.
Embryologists and reproductive endocrinologists provide clinical judgment, experience, and individualized patient care that technology alone cannot replicate.
The most effective approach combines advanced technology with expert medical oversight.
Researchers are continuing to explore how artificial intelligence may contribute to reproductive healthcare.
Potential future applications include:
As the technology develops, AI may become an increasingly valuable tool that helps fertility specialists deliver more informed and individualized care.
Whether you’re trying to conceive naturally or considering fertility treatment, understanding your reproductive health is an important first step.
Tracking your menstrual cycle, recognizing ovulation patterns, and understanding changes over time can provide valuable information to discuss with your healthcare provider.
Fibra is developing smart underwear for women’s reproductive wellness that provides continuous cycle insights to help users better understand their menstrual patterns and ovulation-related changes.
Fibra is intended for general wellness and fertility awareness only. It is not a medical device, does not diagnose infertility, and should not replace professional medical advice or fertility treatment.
Artificial intelligence is opening exciting new possibilities in fertility medicine. By supporting embryo selection and helping clinicians analyze complex data, AI has the potential to improve consistency and enhance decision-making during IVF.
Although research is still evolving, AI represents one of several technological advances that may contribute to more personalized fertility care in the years ahead.
For individuals considering IVF, discussing available technologies with a fertility specialist can help you better understand which approaches may be appropriate for your unique circumstances.
AI may help support embryo selection by providing additional information to fertility specialists. While early research is promising, success rates still depend on many factors, including age, embryo quality, and individual medical circumstances.
No. AI is designed to assist embryologists by analyzing data and identifying patterns. Final clinical decisions remain the responsibility of trained fertility specialists.
No. AI-assisted embryo assessment is becoming more common, but availability varies depending on the clinic and the technology it uses.
No. AI cannot diagnose infertility. A diagnosis requires a comprehensive medical evaluation by a qualified healthcare provider.
